Literature DB >> 27718171

Update on Clinical Utility of Continuous Glucose Monitoring in Type 1 Diabetes.

Nalani Haviland1, John Walsh1, Ruth Roberts2, Timothy S Bailey3.   

Abstract

Since the early 2000s, continuous glucose monitoring (CGM) technology has advanced to become a standard of care in the treatment of type 1 diabetes. Unfortunately, CGM use is not commonly integrated into practice. This article will review the history, technology, and need for systematic training in CGM. Additionally, it will review recent clinical trial data demonstrating the benefits that CGM offers to all people with type 1 diabetes and the clinicians who care for them.

Entities:  

Keywords:  Artificial pancreas; CGM; Continuous glucose monitoring; Insulin therapy; Type 1 diabetes

Mesh:

Substances:

Year:  2016        PMID: 27718171     DOI: 10.1007/s11892-016-0808-5

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  37 in total

1.  Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study.

Authors:  Timothy S Bailey; Howard C Zisser; Satish K Garg
Journal:  Diabetes Technol Ther       Date:  2007-06       Impact factor: 6.118

2.  Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.

Authors:  Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

3.  Establishing a continuous glucose monitoring program.

Authors:  Howard Wolpert
Journal:  J Diabetes Sci Technol       Date:  2008-03

4.  Trends in hospital admissions for hypoglycaemia in England: a retrospective, observational study.

Authors:  Francesco Zaccardi; Melanie J Davies; Nafeesa N Dhalwani; David R Webb; Gemma Housley; Dominic Shaw; James W Hatton; Kamlesh Khunti
Journal:  Lancet Diabetes Endocrinol       Date:  2016-06-09       Impact factor: 32.069

5.  Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors:  William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  N Engl J Med       Date:  2008-09-08       Impact factor: 91.245

6.  Threshold-based insulin-pump interruption for reduction of hypoglycemia.

Authors:  Richard M Bergenstal; David C Klonoff; Satish K Garg; Bruce W Bode; Melissa Meredith; Robert H Slover; Andrew J Ahmann; John B Welsh; Scott W Lee; Francine R Kaufman
Journal:  N Engl J Med       Date:  2013-06-22       Impact factor: 91.245

7.  Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants.

Authors:  Kellee M Miller; Roy W Beck; Richard M Bergenstal; Robin S Goland; Michael J Haller; Janet B McGill; Henry Rodriguez; Jill H Simmons; Irl B Hirsch
Journal:  Diabetes Care       Date:  2013-02-01       Impact factor: 19.112

8.  Economic costs of diabetes in the U.S. in 2012.

Authors: 
Journal:  Diabetes Care       Date:  2013-03-06       Impact factor: 19.112

9.  Effect of acetaminophen on CGM glucose in an outpatient setting.

Authors:  David M Maahs; Daniel DeSalvo; Laura Pyle; Trang Ly; Laurel Messer; Paula Clinton; Emily Westfall; R Paul Wadwa; Bruce Buckingham
Journal:  Diabetes Care       Date:  2015-08-12       Impact factor: 19.112

Review 10.  Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?

Authors:  Sara Trevitt; Sue Simpson; Annette Wood
Journal:  J Diabetes Sci Technol       Date:  2016-05-03
View more
  8 in total

1.  The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC).

Authors:  William H Herman; Barbara H Braffett; Shihchen Kuo; Joyce M Lee; Michael Brandle; Alan M Jacobson; Lisa A Prosser; John M Lachin
Journal:  J Diabetes Complications       Date:  2018-06-12       Impact factor: 2.852

2.  Home Visits for Children and Adolescents with Uncontrolled Type 1 Diabetes.

Authors:  Stephanie S Crossen; James P Marcin; Lihong Qi; Hadley S Sauers-Ford; Allison M Reggiardo; Shelby T Chen; Victoria A Tran; Nicole S Glaser
Journal:  Diabetes Technol Ther       Date:  2019-09-18       Impact factor: 6.118

3.  Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.

Authors:  Rachel S Rigo; Laura E Levin; Donald V Belsito; Maria C Garzon; Rachelle Gandica; Kristen M Williams
Journal:  J Diabetes Sci Technol       Date:  2020-05-09

Review 4.  Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies.

Authors:  Janet B McGill; Andrew Ahmann
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

5.  CONTINUOUS GLUCOSE MONITORING AND TYPE 1 DIABETES MELLITUS CONTROL IN CHILD, ADOLESCENT AND YOUNG ADULT POPULATION - ARGUMENTS FOR ITS USE AND EFFECTS.

Authors:  Karla Rubelj; Gordana Stipančić; Lavinia La Grasta Sabolić; Marija Požgaj Šepec
Journal:  Acta Clin Croat       Date:  2021-12       Impact factor: 0.932

6.  Changing costs of type 1 diabetes care among US children and adolescents.

Authors:  Stephanie Crossen; Guibo Xing; Jeffrey S Hoch
Journal:  Pediatr Diabetes       Date:  2020-03-02       Impact factor: 4.866

Review 7.  Calibration of Minimally Invasive Continuous Glucose Monitoring Sensors: State-of-The-Art and Current Perspectives.

Authors:  Giada Acciaroli; Martina Vettoretti; Andrea Facchinetti; Giovanni Sparacino
Journal:  Biosensors (Basel)       Date:  2018-03-13

8.  Data-Driven Diabetes Education Guided by a Personalized Report for Patients on Insulin Pump Therapy.

Authors:  Danielle Groat; Krystal Corrette; Adela Grando; Vaishak Vellore; Mike Bayuk; George Karway; Mary Boyle; Rozalina McCoy; Kevin Grimm; Bithika Thompson
Journal:  ACI open       Date:  2020-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.